Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 36 studies | 45% ± 19% | |
| naive B cell | 19 studies | 47% ± 17% | |
| memory B cell | 17 studies | 46% ± 17% | |
| precursor B cell | 7 studies | 78% ± 19% | |
| immature B cell | 7 studies | 69% ± 14% | |
| pro-B cell | 5 studies | 82% ± 13% | |
| germinal center B cell | 4 studies | 64% ± 17% | |
| follicular B cell | 3 studies | 65% ± 16% |
Insufficient scRNA-seq data for expression of VPREB3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 99% | 408.62 | 256 / 258 | 40% | 21.96 | 93 / 230 |
| liver | 84% | 21.11 | 190 / 226 | 50% | 6.69 | 203 / 406 |
| kidney | 87% | 33.10 | 77 / 89 | 46% | 2.55 | 413 / 901 |
| lung | 43% | 8.87 | 250 / 578 | 82% | 11.49 | 951 / 1155 |
| thymus | 80% | 39.43 | 523 / 653 | 40% | 8.29 | 239 / 605 |
| intestine | 72% | 350.07 | 694 / 966 | 46% | 10.95 | 242 / 527 |
| brain | 91% | 26.37 | 2413 / 2642 | 25% | 2.20 | 177 / 705 |
| stomach | 57% | 16.21 | 204 / 359 | 55% | 16.29 | 156 / 286 |
| esophagus | 65% | 15.49 | 946 / 1445 | 42% | 3.95 | 76 / 183 |
| prostate | 59% | 19.49 | 144 / 245 | 43% | 3.45 | 217 / 502 |
| breast | 51% | 8.93 | 235 / 459 | 49% | 5.60 | 546 / 1118 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 551.00 | 29 / 29 |
| spleen | 100% | 1234.75 | 241 / 241 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 231.29 | 906 / 929 | 0% | 0 | 0 / 0 |
| skin | 43% | 7.58 | 769 / 1809 | 49% | 12.38 | 233 / 472 |
| pancreas | 34% | 3.88 | 110 / 328 | 53% | 19.19 | 94 / 178 |
| bladder | 38% | 15.57 | 8 / 21 | 46% | 8.93 | 232 / 504 |
| muscle | 80% | 20.33 | 646 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 76% | 15.74 | 34 / 45 |
| ovary | 6% | 0.73 | 11 / 180 | 69% | 4.41 | 297 / 430 |
| heart | 59% | 10.38 | 504 / 861 | 0% | 0 | 0 / 0 |
| adipose | 58% | 13.00 | 698 / 1204 | 0% | 0 | 0 / 0 |
| uterus | 10% | 1.31 | 17 / 170 | 47% | 3.10 | 215 / 459 |
| eye | 0% | 0 | 0 / 0 | 28% | 1.18 | 22 / 80 |
| blood vessel | 21% | 6.51 | 275 / 1335 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006955 | Biological process | immune response |
| GO_0002377 | Biological process | immunoglobulin production |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005576 | Cellular component | extracellular region |
| Gene name | VPREB3 |
| Protein name | Pre-B lymphocyte protein 3 (N27C7-2) (Protein VPreB3) V-set pre-B cell surrogate light chain 3 |
| Synonyms | UNQ355/PRO619 |
| Description | FUNCTION: Associates with the Ig-mu chain to form a molecular complex that is expressed on the surface of pre-B-cells. |
| Accessions | ENST00000248948.4 A8MX21 ENST00000398465.3 Q9UKI3 |